Microbot Medical Inc (NASDAQ:MBOT) Director Yoseph Bornstein sold 44,159 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $1.04, for a total value of $45,925.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Yoseph Bornstein also recently made the following trade(s):

  • On Wednesday, December 6th, Yoseph Bornstein sold 15,375 shares of Microbot Medical stock. The stock was sold at an average price of $1.05, for a total value of $16,143.75.
  • On Tuesday, November 21st, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.21, for a total transaction of $54,450.00.
  • On Tuesday, November 28th, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.07, for a total transaction of $48,150.00.
  • On Tuesday, October 24th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.14, for a total transaction of $57,000.00.
  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.16, for a total transaction of $58,000.00.
  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.38, for a total transaction of $69,000.00.
  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total transaction of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.20, for a total transaction of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.24, for a total transaction of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total transaction of $59,000.00.

Shares of Microbot Medical Inc (NASDAQ:MBOT) traded down $0.02 on Wednesday, reaching $1.02. 524,325 shares of the company’s stock traded hands, compared to its average volume of 874,478. Microbot Medical Inc has a twelve month low of $1.00 and a twelve month high of $9.94.

An institutional investor recently raised its position in Microbot Medical stock. Vanguard Group Inc. boosted its stake in Microbot Medical Inc (NASDAQ:MBOT) by 252.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 159,992 shares of the biotechnology company’s stock after buying an additional 114,561 shares during the period. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 at the end of the most recent reporting period. 4.72% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Microbot Medical Inc (MBOT) Director Yoseph Bornstein Sells 44,159 Shares” was published by American Banking News and is owned by of American Banking News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.americanbankingnews.com/2017/12/13/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-44159-shares.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.